Filing Details
- Accession Number:
- 0001161697-24-000490
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-29 20:08:45
- Reporting Period:
- 2024-11-26
- Accepted Time:
- 2024-11-29 20:08:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1763511 | Brian Elsbernd | 355 Alhambra Circle Suite 801 Coral Gables FL 33134 | Chief Compliance/Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2024-11-26 | 50,244 | $4.01 | 174,677 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2024-11-26 | 9,300 | $21.65 | 165,377 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2024-11-26 | 9,756 | $4.01 | 175,133 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2024-11-26 | 3,956 | $21.58 | 171,177 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to Purchase Common Stock | Disposition | 2024-11-26 | 50,244 | $0.00 | 50,244 | $4.01 |
| Common Stock | Options to Purchase Common Stock | Disposition | 2024-11-26 | 9,756 | $0.00 | 9,756 | $4.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,104,766 | 2025-01-02 | No | 4 | M | Direct | |
| 1,095,010 | 2025-01-02 | No | 4 | M | Direct |
Footnotes
- Shares were sold for tax purposes and to pay the exercise price of the options and not as a result of a disagreement with the Company. Mr. Elsbernd remains an executive officer of the Company.
- Options vested in three annual tranches beginning on January 2, 2019.
Billionaire Hedge Funds
